{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:14:51Z","timestamp":1788012891299,"version":"build-2784847793"},"reference-count":149,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiac.2025.102772","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:15:56Z","timestamp":1752603356000},"page":"102772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccination strategies for transplantation in Japan (solid organ transplantation and hematopoietic stem cell transplantation)"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-9528","authenticated-orcid":false,"given":"Takeshi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-3857","authenticated-orcid":false,"given":"Satoshi","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3315-8478","authenticated-orcid":false,"given":"Ayumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-7679","authenticated-orcid":false,"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102772_bib5","doi-asserted-by":"crossref","first-page":"279 e1","DOI":"10.1016\/j.jtct.2022.12.013","article-title":"An analysis of the worldwide utilization of hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"29","author":"Tokaz","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jiac.2025.102772_bib6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102772_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2025.2489659","article-title":"Vaccination strategies for solid organ transplant candidates and recipients: insights and recommendations","volume":"24","author":"Radcliffe","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jiac.2025.102772_bib8","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.clinthera.2017.07.005","article-title":"A comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients","volume":"39","author":"Chong","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2025.102772_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib10","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European conference on infections in leukaemia (ecil 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2025.102772_bib11","article-title":"Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or car t-cell therapy","volume":"25","author":"Reynolds","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2022.11.005","volume":"86","author":"Miller","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2025.102772_bib13","series-title":"Committee for the guideline for vaccination of the immunocompromised host 2024. Guideline for vaccination of the immunocompromised host 2024","year":"2024"},{"key":"10.1016\/j.jiac.2025.102772_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00134-019-05597-y","article-title":"Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2025.102772_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamapediatrics.2018.4954","article-title":"Incidence of hospitalization for vaccine-preventable infections in children following solid organ transplant and associated morbidity, mortality, and costs","volume":"173","author":"Feldman","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jiac.2025.102772_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10687","article-title":"Vaccine-preventable infections among solid organ transplant recipients in Switzerland","volume":"6","author":"Walti","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2025.102772_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczynski","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib19","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood.V86.10.3979.bloodjournal86103979","article-title":"Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients","volume":"86","author":"Ochs","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102772_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199709109152","article-title":"Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis","volume":"26","author":"Roy","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jiac.2025.102772_bib21","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/j.vaccine.2021.07.022","article-title":"Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant","volume":"39","author":"Colton","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102772_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00062752-199603060-00010","article-title":"Immunologic reconstitution following stem cell transplantation","volume":"3","author":"Small","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jiac.2025.102772_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"Idsa clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/annonc\/mdy117","article-title":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-guideline of the infectious diseases working party (agiho) of the German society for hematology and medical oncology (dgho)","volume":"29","author":"Rieger","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jiac.2025.102772_bib27","series-title":"Guidelines for hematopoietic cell transplantation: vaccination","year":"2023"},{"key":"10.1016\/j.jiac.2025.102772_bib28","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1182\/blood.V95.12.3683","article-title":"Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants","volume":"95","author":"Kulkarni","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102772_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(03)14256-0","article-title":"Measles-associated encephalitis in children with renal transplants: a predictable effect of waning herd immunity?","volume":"362","author":"Kidd","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2025.102772_bib30","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1600-6143.2006.01330.x","article-title":"Measles-associated encephalopathy in children with renal transplants","volume":"6","author":"Turner","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ckj\/sfs036","article-title":"Chickenpox infection after renal transplantation","volume":"5","author":"Kaul","year":"2012","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jiac.2025.102772_bib32","first-page":"604","article-title":"An outbreak of chickenpox in adult renal transplant recipients","volume":"5","author":"Shahbazian","year":"2007","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib33","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.vaccine.2021.04.049","article-title":"Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients","volume":"39","author":"Groeneweg","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102772_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14687","article-title":"Live-attenuated vaccination for measles, mumps, and rubella in pediatric liver transplantation","volume":"28","author":"Keutler","year":"2024","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib35","series-title":"The adult organ transplant vaccination guidelines","year":"2018"},{"key":"10.1016\/j.jiac.2025.102772_bib36","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.vaccine.2009.02.094","article-title":"Humoral immunogenicity to Measles, rubella, and varicella-zoster vaccines in biliary atresia children","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102772_bib37","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102772_bib38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/ajt.16937","article-title":"Live virus vaccination following pediatric liver transplantation: outcomes from two academic children's hospitals","volume":"22","author":"Newman","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13571","article-title":"Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018","volume":"23","author":"Suresh","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2025.102772_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13937","article-title":"Safety of lavs administered after pediatric lt","volume":"25","author":"Funaki","year":"2021","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajt.2024.07.005","article-title":"Assessing clinical benefits of live-attenuated vaccination in post-liver transplant patients: analysis of breakthrough infections and natural boosters","volume":"25","author":"Shinjoh","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1442-200X.1996.tb03472.x","article-title":"Clinical features of measles in immunocompromised children","volume":"38","author":"Nakano","year":"1996","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.jiac.2025.102772_bib44","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","article-title":"Severe measles in immunocompromised patients","volume":"267","author":"Kaplan","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2025.102772_bib45","first-page":"802","article-title":"Live-attenuated vaccine administration after hematopoietic stem cell transplantation","volume":"55","author":"Koh","year":"2014","journal-title":"Jpn J Clin Hematol"},{"key":"10.1016\/j.jiac.2025.102772_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V99.1.83","article-title":"Measles in bone marrow transplant recipients during an outbreak in sao paulo, Brazil","volume":"99","author":"Machado","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102772_bib47","series-title":"Vaccination of transplant recipients","first-page":"871","author":"Ljungman","year":"2016"},{"key":"10.1016\/j.jiac.2025.102772_bib48","series-title":"Herpes simplex and varicella-zoster virus infection after hematopoietic stem cell or solid organ transplantation","first-page":"513","author":"Joshua","year":"2016"},{"key":"10.1016\/j.jiac.2025.102772_bib49","series-title":"Per ljungman DS","first-page":"81","article-title":"Risks and epidemiology of infections after hematopoietic stem cell transplantation","author":"Gea-Banacloche","year":"2016"},{"key":"10.1016\/j.jiac.2025.102772_bib50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102772_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14126","article-title":"Pneumococcal pneumonia in adult hospitalised solid organ transplant recipients: nationwide, population-based surveillance","volume":"75","author":"Huang","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jiac.2025.102772_bib52","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2006.01705.x","article-title":"Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jiac.2025.102772_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jiac.2025.102772_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7401a1","article-title":"Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged >\/=50 years: recommendations of the advisory committee on immunization practices - united States, 2024","volume":"74","author":"Kobayashi","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2025.102772_bib57","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib58","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/591537","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients","volume":"47","author":"Kumar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib61","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2141.2002.03457.x","article-title":"Early and late invasive pneumococcal infection following stem cell transplantation: a European bone marrow transplantation survey","volume":"117","author":"Engelhard","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2025.102772_bib62","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1086\/523583","article-title":"A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients","volume":"45","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2019.10.006","article-title":"Clinical effectiveness of conjugate pneumococcal vaccination in hematopoietic stem cell transplantation recipients","volume":"26","author":"Roberts","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib64","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ287","article-title":"Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged >\/=2 years: an open-label study","volume":"61","author":"Cordonnier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib66","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ajh.26493","article-title":"Immunogenicity of a 5-dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Garcia Garrido","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jiac.2025.102772_bib67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cmi.2022.12.007","article-title":"Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial","volume":"29","author":"Okinaka","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2025.102772_bib68","author":"Kobayashi"},{"key":"10.1016\/j.jiac.2025.102772_bib69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<85::AID-JMV14>3.0.CO;2-H","article-title":"Efficacy of influenza vaccination in adult liver transplant recipients","volume":"61","author":"Soesman","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiac.2025.102772_bib70","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib71","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/ajt.17055","article-title":"Effect of influenza vaccination in solid organ transplant recipients: a nationwide population-based cohort study","volume":"22","author":"Harboe","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib72","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2215\/CJN.05430610","article-title":"Outcomes associated with influenza vaccination in the first year after kidney transplantation","volume":"6","author":"Hurst","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jiac.2025.102772_bib73","doi-asserted-by":"crossref","first-page":"E533","DOI":"10.1111\/1469-0691.12044","article-title":"Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease","volume":"18","author":"Perez-Romero","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2025.102772_bib74","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib75","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/425004","article-title":"Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy","volume":"39","author":"Nichols","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib76","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/cid\/ciy792","article-title":"Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: a cross-sectional, prospective, observational study","volume":"68","author":"Pinana","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib77","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogeneic t cell-depleted and autologous bmt recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib78","author":"Gerber"},{"key":"10.1016\/j.jiac.2025.102772_bib79","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00007890-199802270-00007","article-title":"Transmission of hepatitis b virus from hepatitis b core antibody-positive donors in living related liver transplants","volume":"65","author":"Uemoto","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2025.102772_bib80","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/jvh.13740","article-title":"Incidence of post-transplant hepatitis b virus reactivation with the use of kidneys from donors with resolved hepatitis b virus infection","volume":"29","author":"Yamada","year":"2022","journal-title":"J Viral Hepat"},{"issue":"Suppl B","key":"10.1016\/j.jiac.2025.102772_bib81","doi-asserted-by":"crossref","first-page":"59B","DOI":"10.1155\/2000\/548206","article-title":"Ineffectiveness of hepatitis b vaccination in cirrhotic patients waiting for liver transplantation","volume":"14","author":"Villeneuve","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jiac.2025.102772_bib82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198408233110803","article-title":"Hepatitis b vaccine in patients receiving hemodialysis. Immunogenicity and efficacy","volume":"311","author":"Stevens","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102772_bib83","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0163-4453(05)80007-6","article-title":"Poor response to a recombinant hepatitis b vaccine in dialysis patients","volume":"22","author":"Fleming","year":"1991","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2025.102772_bib84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1492-7535.2005.01155.x","article-title":"Antibody response to engerix-b and recombivax-hb hepatitis b vaccination in end-stage renal disease","volume":"9","author":"Lacson","year":"2005","journal-title":"Hemodial Int"},{"key":"10.1016\/j.jiac.2025.102772_bib85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2007.04.012","article-title":"The underestimated risk of hepatitis a and hepatitis B: benefits of an accelerated vaccination schedule","volume":"12","author":"Keystone","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib86","author":"Harris"},{"key":"10.1016\/j.jiac.2025.102772_bib89","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S1413-86702008000400009","article-title":"Double-dose hepatitis b vaccination in cirrhotic patients on a liver transplant waiting list","volume":"12","author":"Bonazzi","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib90","first-page":"1590","article-title":"Failure of hepatitis b immunization in liver transplant recipients: results of a prospective trial","volume":"85","author":"Carey","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2025.102772_bib91","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jmv.21995","article-title":"Virological and clinical characteristics on reactivation of occult hepatitis b in patients with hematological malignancy","volume":"83","author":"Sugauchi","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiac.2025.102772_bib92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/bmt.2010.70","article-title":"Risk of hepatitis b surface antigen seroreversion after allogeneic hematopoietic sct","volume":"46","author":"Vigano","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib93","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbmt.2008.08.007","article-title":"Hb vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous hbv infection","volume":"14","author":"Onozawa","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib94","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.1840180204","article-title":"Adoptive transfer of immunity to hepatitis b virus after t cell-depleted allogeneic bone marrow transplantation","volume":"18","author":"Ilan","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jiac.2025.102772_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx007","article-title":"Herpes zoster and recurrent Herpes zoster","volume":"4","author":"Shiraki","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib96","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of Herpes zoster vaccine in adults aged >\/=60 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwx245","article-title":"Long-term effectiveness of the live zoster vaccine in preventing shingles: a cohort study","volume":"187","author":"Baxter","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiac.2025.102772_bib98","article-title":"Long-term protection against Herpes zoster by the adjuvanted recombinant zoster vaccine: interim efficacy, immunogenicity, and safety results up to 10 years after initial vaccination","volume":"9","author":"Strezova","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib99","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted Herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102772_bib100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib101","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/TP.0000000000003621","article-title":"Evaluation of recombinant Herpes zoster vaccine for primary immunization of varicella-seronegative transplant recipients","volume":"105","author":"L'Huillier","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2025.102772_bib102","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(18)30631-7","article-title":"Inactivated Varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Winston","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2025.102772_bib103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of Herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2025.102772_bib104","article-title":"Cellular immune response after vaccination with an adjuvanted, recombinant zoster vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Koldehoff","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jiac.2025.102772_bib105","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/bloodadvances.2020003749","article-title":"Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation","volume":"5","author":"Baumrin","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jiac.2025.102772_bib106","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QCO.0000000000000845","article-title":"Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients","volume":"35","author":"Provost-Olewczynska","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81099-2","article-title":"Covid-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study","volume":"14","author":"Infante-Dominguez","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2025.102772_bib108","article-title":"Covid-19 mortality in vaccinated vs. unvaccinated liver & kidney transplant recipients: a single-center United States propensity score matching study on historical data","volume":"10","author":"Hardgrave","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jiac.2025.102772_bib109","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ajt.2024.03.016","article-title":"Excess mortality in covid-19-affected solid organ transplant recipients across the pandemic","volume":"24","author":"Yamanaga","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ajt.16840","article-title":"Changing trends in mortality among solid organ transplant recipients hospitalized for covid-19 during the course of the pandemic","volume":"22","author":"Heldman","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib111","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.transproceed.2024.05.031","article-title":"Reasons for covid-19 vaccine hesitancy among patients listed for solid organ transplants","volume":"56","author":"Kalavacherla","year":"2024","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jiac.2025.102772_bib112","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.6822","article-title":"Immunogenicity and risk factors associated with poor humoral immune response of sars-cov-2 vaccines in recipients of solid organ transplant: a systematic review and meta-analysis","volume":"5","author":"Manothummetha","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2025.102772_bib113","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.ajt.2024.03.011","article-title":"Longitudinal outcomes of covid-19 in solid organ transplant recipients from 2020 to 2023","volume":"24","author":"Solera","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib114","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/TP.0000000000004535","article-title":"Vaccine effectiveness against the sars-cov-2 b.1.1.529 omicron variant in solid organ and islet transplant recipients in England: a national retrospective cohort study","volume":"107","author":"Callaghan","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2025.102772_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125030","article-title":"Outcome of covid-19 in allogeneic stem cell transplant recipients: results from the epicovideha registry","volume":"14","author":"Busca","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2025.102772_bib116","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3026(20)30429-4","article-title":"Clinical characteristics and outcomes of covid-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study","volume":"8","author":"Sharma","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jiac.2025.102772_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2483","article-title":"Covid-19 in hematopoietic stem-cell transplant recipients: a systematic review and meta-analysis of clinical characteristics and outcomes","volume":"33","author":"Randi","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jiac.2025.102772_bib118","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjh.17918","article-title":"Immunogenicity and safety of the bnt162b2 mrna covid-19 vaccine in haematopoietic stem cell transplantation recipients","volume":"196","author":"Shem-Tov","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2025.102772_bib119","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.26769","article-title":"Predictors of impaired antibody response after sars-cov-2 mrna vaccination in hematopoietic cell transplant recipients: a Japanese multicenter observational study","volume":"98","author":"Mori","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jiac.2025.102772_bib120","article-title":"The covid-19 mrna bnt163b2 vaccine was well tolerated and highly immunogenic in young adults in long follow-up after haematopoietic stem cell transplantation","volume":"9","author":"Matkowska-Kocjan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jiac.2025.102772_bib121","article-title":"Third bnt162b2 mrna sars-cov-2 vaccine dose significantly enhances immunogenicity in recipients of allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Henig","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jiac.2025.102772_bib122","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood.2021014232","article-title":"Antibody response after 2 and 3 doses of sars-cov-2 mrna vaccine in allogeneic hematopoietic cell transplant recipients","volume":"139","author":"Maillard","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102772_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (acip)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jiac.2025.102772_bib125","unstructured":"Japan Institute for Health Security. Tetanus. 12 Jan 2021. https:\/\/id-info.jihs.go.jp\/diseases\/ha\/tetanis\/010\/index.html. [Accessed 11 July 2025]."},{"key":"10.1016\/j.jiac.2025.102772_bib126","unstructured":"Japan Institute for Health Security. Pertussis. 22 April 2025. https:\/\/id-info.jihs.go.jp\/diseases\/ha\/pertussis\/020\/2504_pertussis_RA.html. [Accessed 11 July 2025]."},{"key":"10.1016\/j.jiac.2025.102772_bib127","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/infdis\/162.2.496","article-title":"Response to tetanus toxoid immunization after allogeneic bone marrow transplantation","volume":"162","author":"Ljungman","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib128","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bbmt.2009.07.018","article-title":"Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (tdap) after autologous peripheral blood stem cell transplantation","volume":"15","author":"Small","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/CVI.05675-11","article-title":"Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-hib vaccine era","volume":"19","author":"Nix","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jiac.2025.102772_bib130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jiac.2020.04.021","article-title":"Haemophilus influenzae type b capsular polysaccharide antibody levels in Japanese young patients with hematological malignancies and asplenia","volume":"26","author":"Takeshita","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102772_bib131","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/j.vaccine.2023.06.034","article-title":"Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008-2020","volume":"41","author":"Orangzeb","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102772_bib132","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bmt.1701424","article-title":"Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation","volume":"22","author":"Vance","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00007890-199403150-00009","article-title":"Polysaccharide conjugate vaccine responses in bone marrow transplant patients","volume":"57","author":"Guinan","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2025.102772_bib134","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/bmt.2016.181","article-title":"Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study","volume":"51","author":"van Veen","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.semtcvs.2004.09.015","article-title":"Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences","volume":"16","author":"Chakinala","year":"2004","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jiac.2025.102772_bib136","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1183\/09031936.06.00105505","article-title":"A single-season prospective study of respiratory viral infections in lung transplant recipients","volume":"28","author":"Milstone","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2025.102772_bib137","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccm.2017.07.012","article-title":"Respiratory viral infections in solid organ and hematopoietic stem cell transplantation","volume":"38","author":"Paulsen","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jiac.2025.102772_bib138","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13511","article-title":"American society of transplantation infectious diseases community of P. Rna respiratory viral infections in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib139","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent rsv prefusion f vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102772_bib140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion f protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102772_bib141","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mrna-based rsv pref vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102772_bib142","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ajt.2024.02.003","article-title":"The respiratory syncytial virus vaccines are here: implications for solid organ transplantation","volume":"24","author":"Trubin","year":"2024","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.jiac.2025.102772_bib143","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1111\/j.1600-6143.2009.02906.x","article-title":"Human papillomavirus infection in solid organ transplant recipients","volume":"9","author":"Kwak","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2024.107927","article-title":"Prevalence of cervical human papillomavirus in kidney transplant recipients: a systematic review and meta-analysis","volume":"182","author":"Ring","year":"2024","journal-title":"Prev Med"},{"key":"10.1016\/j.jiac.2025.102772_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1452916","article-title":"Quadrivalent hpv (4vhpv) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant","volume":"14","author":"Miyaji","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2025.102772_bib147","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib148","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/bmt.2017.210","article-title":"Risks factors and timing of genital human papillomavirus (Hpv) infection in female stem cell transplant survivors: a longitudinal study","volume":"53","author":"Shanis","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib149","doi-asserted-by":"crossref","first-page":"211","DOI":"10.6004\/jnccn.2018.7005","article-title":"Secondary neoplasms of the female lower genital tract after hematopoietic cell transplantation","volume":"16","author":"Chang","year":"2018","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jiac.2025.102772_bib150","doi-asserted-by":"crossref","first-page":"1016 e1","DOI":"10.1016\/j.jtct.2021.08.020","article-title":"Increased incidence of human papillomavirus-related precancer or second malignancy among allogeneic stem cell transplantation patients: a seer-medicare population study","volume":"27","author":"Zhao","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jiac.2025.102772_bib151","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaoncol.2019.6722","article-title":"Immune response following quadrivalent human papillomavirus vaccination in women after hematopoietic allogeneic stem cell transplant: a nonrandomized clinical trial","volume":"6","author":"Stratton","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jiac.2025.102772_bib152","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-hla antibody after pandemic h1n1 and seasonal influenza immunization in kidney transplant recipients","volume":"11","author":"Katerinis","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib153","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40264-017-0532-3","article-title":"Adjuvanted (as03) a\/h1n1 2009 pandemic influenza vaccines and solid organ transplant rejection: systematic signal evaluation and lessons learnt","volume":"40","author":"Dos Santos","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.jiac.2025.102772_bib154","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3389\/fimmu.2020.01917","article-title":"Effect of influenza vaccination inducing antibody mediated rejection in solid organ transplant recipients","volume":"11","author":"Cordero","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2025.102772_bib155","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.healun.2018.03.001","article-title":"Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis","volume":"37","author":"Mulley","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jiac.2025.102772_bib156","article-title":"Solid organ rejection following sars-cov-2 vaccination or covid-19 infection: a systematic review and meta-analysis","volume":"10","author":"Alhumaid","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jiac.2025.102772_bib157","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/cid\/ciab969","article-title":"Respiratory syncytial virus, human metapneumovirus, and parainfluenza virus infections in lung transplant recipients: a systematic review of outcomes and treatment strategies","volume":"74","author":"de Zwart","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib158","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae342","article-title":"Therapeutic myths in solid organ transplantation infectious diseases","volume":"11","author":"Goodlet","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2025.102772_bib159","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2025.102772_bib160","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1016\/j.vaccine.2023.11.033","article-title":"Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: a national questionnaire survey in Japan","volume":"41","author":"Tanaka","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102772_bib161","article-title":"Financial burden as a potential barrier to vaccine completion in post-hematopoietic stem cell transplant patients in Japan","volume":"16","author":"Ogawa","year":"2024","journal-title":"Cureus"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:11:49Z","timestamp":1755551509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":149,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1341321X25001692"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102772","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination strategies for transplantation in Japan (solid organ transplantation and hematopoietic stem cell transplantation)","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102772"}}